Minimally invasive surgery for maximally invasive tumors—pelvic exenterations for rectal cancers: are we prepared?
10.7602/jmis.2022.25.4.127
- Author:
Joe King Man FAN
1
Author Information
1. Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
- Publication Type:EDITORIAL
- From:Journal of Minimally Invasive Surgery
2022;25(4):127-128
- CountryRepublic of Korea
- Language:English
-
Abstract:
Despite the public awareness of colorectal cancer screening with more and more early premalignant or malignant lesions detected, surgeons still face the challenges of operating for a patient suffering from locally advanced rectal carcinoma which required pelvic exenterations, and surgical outcomes mostly influenced by margin status, adjuvant chemotherapy, positive lymph nodes and liver metastasis, etc. Open pelvic exenteration has been the adopted approach in the past and laparoscopic surgery is another option in expert centers. A study in this issue of the Journal of Minimally Invasive Surgery demonstrated promising results of minimally invasive approaches for pelvic exenteration in patients with locally advanced rectal carcinoma, with overall complication rate of 28.2% with a 7.3% circumferential resection margin positivity and with no distal margin involvement, with local recurrence rate of 8.1% and overall survival of 85.2% by 2-year follow-up. We are expecting more results in the future to support the routine implementation of minimally invasive pelvic exenterations.
